MCL1 and acute myeloid leukemia: As MCL1 as a key regulator of the compensation mechanism against apoptosis upon BCL2 inhibition [38], MCL1 inhibition induced by HDAC3 may be a key factor for synergistic killing of AML cells with venetoclax.